BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/7/2015 11:06:00 AM | Browse: 1722 | Download: 1887
Publication Name World Journal of Gastroenterology
Manuscript ID 13935
Country United States
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis
Manuscript Source Unsolicited Manuscript
All Author List Arseima Y Del Valle-Pinero, LeeAnne B Sherwin, Ethan M Anderson, Robert M Caudle and Wendy A Henderson
Funding Agency and Grant Number
Funding Agency Grant Number
National Institutes of Health grant NS045614
Ruth L. Kirschstein National Research Service Award 1F31 DK083165-01A1
Division of Intramural Research, National Institute of Nursing Research 1ZIANR000018-01-05(to Henderson WA)
Intramural Training Award to Del Valle-Pinero AY and Sherwin LB
Corresponding Author Dr. Wendy A Henderson, PhD, Chief, Digestive Disorders Unit, Biobehavioral Branch, Division of Intramural Research, National Institute of Nursing Research, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, United States. hendersw@mail.nih.gov
Key Words Irritable bowel syndrome; Vasoactive intestinal peptide; Trinitrobenzene sulfonic acid; Gene expression; PCR arrays
Core Tip The present study reports evidence of altered vasoactive intestinal peptide (VIP) in both humans with irritable bowel syndrome (IBS) and a rat model with induced colitis by trinitrobenzene sulfonic acid. Together these observations provide additional evidence of the role of VIP, and the potential therapeutic application in patients with IBS. The results provide a basis for future studies to elucidate the understanding of the expression, physiology, and pharmacological properties of VIP.
Publish Date 2015-01-07 11:07
Citation Del Valle-Pinero AY, Sherwin LB, Anderson EM, Caudle RM, Henderson WA. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis. World J Gastroenterol 2015; 21(1): 155-163
URL http://www.wjgnet.com/1007-9327/full/v21/i1/155.htm
DOI http://dx.doi.org/10.3748/wjg.v21.i1.155
Full Article (PDF) WJG-21-155.pdf
Full Article (Word) WJG-21-155.doc